EssilorLuxottica SA
EssilorLuxottica SA (ISIN FR0000121667) traded at 163.70 € on August 21, 2026. 1 of 1 sharewise users currently rate it a buy.
Pros & cons of EssilorLuxottica
EssilorLuxottica S.A. is a globally leading ophthalmic optics company that emerged from the merger of the French Essilor International and the Italian Luxottica in October 2018 [1]. The group’s business model is based on deep vertical integration along the entire value chain for vision aids, from the development and manufacture of lenses and frames to brand building and retail [2]. The company covers two core segments: Vision Care (eyeglass lenses and contact lenses) and Sun Business (sunglasses) [3]. Among its best-known products are the Varilux progressive lens, the Transitions photochromic lenses, and the iconic frame and sunglass brands Ray-Ban and Oakley [1] [4]. The group describes its approach as an “open model” of a network society that shares its own assets, and places strong emphasis on innovation, quality across all price points, and multi-channel distribution through brands such as Sunglass Hut and LensCrafters [3]. The supply chain appears to be heavily in-house: EssilorLuxottica operates numerous own or partner-run labs for lens surfacing and a global production infrastructure. Key external suppliers may exist in the area of coatings (e.g., PPG Industries for Transitions lenses) or mineral glass blanks [1]. In its competitive environment, the group faces some focused rivals. In the lens segment, the sharpest competitors are Zeiss Vision Care (Carl Zeiss AG) and Hoya Vision Care – both excel in strong optical research and development, but compared to EssilorLuxottica they possess a significantly smaller portfolio of iconic frame and sunglass brands and are less deeply embedded in retail [2]. While competition is fundamentally technological, EssilorLuxottica benefits from its unique ability to understand eyewear not as a single product but as a platform of lenses, frames, digital tools, and data, thus forming a closed ecosystem that keeps multiple value chain stages under its own control [5]. With a global market share of around 30% in the vision segment and an enormous brand reach compared to competitors more focused on professional optics or regional markets, the group occupies a dominant market position [1].
- [1] de.wikipedia.org
- [2] ad-hoc-news.de
- [3] essilorluxottica.com
- [4] ch.marketscreener.com
- [5] ad-hoc-news.de
Performance of EssilorLuxottica SA vs. its peers
| Security | YTD | 3y |
|---|---|---|
| EssilorLuxottica SA | -39.57% | -6.88% |
| Sartorius Stedim Biotech S.A. | -7.51% | -21.38% |
| bioMerieux S.A. | -32.08% | -19.86% |
| Idexx Laboratories Inc. | -18.44% | 7.82% |